Clinical trials about amplitude modulated RF-HyperThermia

The Andromedic HYDEEP 600WM, a deep local hyperthermia (mHT) device for targeted RF-hyperthermia therapy has been used in several clinical trials. Explore the clinical results and learn more about locoregional hyoperthermia from a clinical point of view

Clinical research with Andromedic HyDeep 600WM amplitude modulate hyperthermia device

Quasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response

Quasi feasibility study(case control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response
Quasi feasibility study(case control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response

Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO

Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO
Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO poster

Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response full text

Preliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma
Preliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma

Other clinical research about amplitude modulate hyperthermia

mHT as adjuvant, neoadjuvant and palliative therapy to support oncological/neoplastic pathologies

Extensive research has been conducted using amplitude modulated RF-hyperthermia in conjunction with various chemoradio or immuno therapies or as stand alone or as palliative treatment

A recent reviews regarding the Clinical Validation of mHT can be read here 

An impressive collection of European clinical studies & results with oncological hyperthermia was also presented by our colleague Prof. Dr. Giammaria Fiorentini (Coordinator of the Italian Network of the International Society of Clinical Hyperthermia since 2020) :   Hyperthermia – clinical trials results and case reports by G Giorentini 20 sept 2023 room 9 Rome

Scientific papers Hyperthermia

mHT GUIDELINES

Would you like to receive more information?

Contact us now